1. Japan Stocks

  2. •

    Retail trade

  3. •

    Drugstore chains
Sundrug Co., Ltd.

Sundrug Co., Ltd.

TTSE:9989
3,656.00
JPY
+44.00
(+1.22%)
457.40BMarket Cap
Nov 13Next Earn
Sundrug Co., Ltd.
TSE:9989
(Tokyo Stock Exchange)

Recent

price

3,656.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
2,861.27
3,068.99
3,232.15
3,552.81
3,636.91
4,167.39
4,472.44
4,824.44
5,031.06
5,284.59
5,426.09
5,548.64
5,905.26
6,428.8
6,855.27
7,202.36
- -
Revenue per Share
86.25
99.8
118.65
124.99
133.48
178.43
197.32
212.31
204.75
202.67
216.67
204.02
219.83
249.07
262.9
268.36
- -
Basic EPS, GAAP
100.75
79.05
112.58
192.96
19.14
202.29
142.74
202.54
170.22
179.39
130.76
101.72
96.36
25.34
58.98
103.96
- -
Free Cash Flow per Basic Share
15.49
17.99
21.98
25.99
30.21
34.97
45.28
54.46
65.99
67.26
68.98
70.02
85.98
106.99
121.97
129.96
- -
Dividend per Share
620.74
702.6
799.47
898.12
959.48
1,102.58
1,166.4
1,324.63
1,463.33
1,598.12
1,754.96
1,886.62
2,021.2
2,164.05
2,305.89
2,444.81
- -
Book Value per Share
574.31
661.38
761.44
861.95
919.92
1,062.45
1,126.16
1,284.07
1,423.64
1,554.25
1,709.6
1,835.71
1,943.34
2,085.87
2,231.79
2,375.57
- -
Tangible Book Value per Share
126
126
126
126
123
121
118
117
117
117
117
117
117
117
117
117
117
Basic Weighted Avg Shares
360,655
386,836
407,401
447,819
445,818
503,773
528,394
564,215
588,069
617,769
634,310
648,734
690,462
751,777
801,811
842,512
- -
Sales/Revenue/Turnover
12.33
5.76
6.07
6.27
5.82
6.56
6.45
6.4
5.99
5.93
5.89
5.25
5.42
5.45
5.55
5.56
- -
Operating Margin (%)
4,191
4,914
5,307
5,609
6,225
6,419
6,972
7,788
8,242
8,359
8,663
10,209
12,068
15,127
17,282
18,760
- -
Depreciation Expense
10,871
12,580
14,955
15,754
16,362
21,569
23,312
24,829
23,933
23,692
25,329
23,853
25,703
29,126
30,750
31,392
- -
Net Income, GAAP
42.38
43.97
40.24
42.03
38.42
35.18
32.28
32.15
31.76
31.62
31.89
31.21
31.84
29.41
29.42
31.46
- -
Effective Tax Rate (%)
3.01
3.25
3.67
3.52
3.67
4.28
4.41
4.4
4.07
3.84
3.99
3.68
3.72
3.87
3.84
3.73
- -
Profit Margin (%)
27,649
32,974
39,687
48,053
45,603
58,753
55,367
65,471
78,095
90,770
99,146
103,492
92,658
52,777
88,270
104,029
- -
Working Capital
4,083
1,374
657
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
33,866
42,076
- -
LT Debt
78,242
88,561
100,771
113,205
115,987
133,285
136,335
154,828
171,055
186,821
205,155
220,592
236,327
253,089
269,714
286,001
- -
Total Equity
12.72
13.14
14.24
14.25
13.23
16.36
16.3
16.09
14.17
13.5
12.52
10.68
10.85
10.71
10.26
9.74
- -
Return on Invested Capital (%)
13.13
14.04
15.29
14.59
14.24
17.31
17.3
17.06
14.69
13.24
12.93
11.21
11.26
11.12
10.35
9.85
- -
Return on Capital (%)
14.73
15.08
15.8
14.73
14.28
17.31
17.29
17.06
14.69
13.24
12.92
11.21
11.25
11.9
11.76
11.3
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
6,400
6,139
- -
LT Borrowings
37,215
42,076
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
117
117
117
Market Capitalization
507,355
457,403
445,120

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
220,924
238,064
- -
Cash, Cash Equivalents & STI
66,137
70,523
- -
Accounts Receivable, Net
27,198
32,330
- -
Inventories
103,572
110,322
- -
Total Current Liabilities
123,899
134,035
- -
Payables & Accruals
- -
- -
- -
ST Debt
6,400
6,139
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.97%
6.87%
6.04%
Free Cash Flow
7.97%
21.59%
76.3%
Net Income, GAAP
3.98%
4.58%
2.09%
Sales/Revenue/Turnover
5.29%
5.86%
5.08%
Total Cash Common Dividend
14.06%
13.87%
6.56%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
801,811
2026
- -
- -
- -
- -
842,512
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
262.9
2026
- -
- -
- -
- -
268.36
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
121.97
2026
- -
- -
- -
- -
129.96
2027
- -
- -
- -
- -
- -
Similar Companies
CVS Health Corporation (NYSE:CVS)
MatsukiyoCocokara & Co. (TSE:3088)
Guardian Pharmacy Services, Inc. (NYSE:GRDN)
TSURUHA Holdings, Inc. (TSE:3391)
MedPlus Health Services Ltd. (NSE:MEDPLUS)
Raia Drogasil S.A. (B3:RADL3)
Business
Sundrug Co., Ltd. (9989:TYO; SDGCF:OTCPK) operates drug stores, dispensing pharmacies, and discount stores primarily in Japan. The company conducts its activities through two main segments: the Drug Store Business, which sells pharmaceutical products including prescription and over-the-counter medications, cosmetics, daily necessities, and general merchandise; and the Discount Store Business, which offers food products, household goods, and sundry items. Sundrug Co., Ltd. serves retail customers across urban and suburban areas nationwide, with a network exceeding 950 stores focused on health, beauty, and convenience needs. Founded in 1957 by Yukimasa Tada and headquartered in Fuchu, Tokyo, Japan, the company maintains a strong emphasis on efficient supply chain management, customer loyalty programs, and digital enhancements such as e-commerce platforms and inventory systems. In recent developments, Sundrug Co., Ltd. reports robust financial performance for the six months ending September 30, 2025, with net sales growth of 5.8% year-over-year, alongside upward revisions to full-year forecasts and increased dividends. The company continues aggressive store expansion, adding approximately 50 locations annually, while investing in technology for improved operations and sustainability initiatives like plastic reduction. Earlier strategic moves include the 2022 acquisition of Daiya K.K. to bolster its retail footprint.